Treatment of Blastocystis Hominis infection ameliorates Hashimoto’s thyroiditis: Relation to IL-17
Not Applicable
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR201909495111649
- Lead Sponsor
- Alexandria University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with Hashimotos thyroiditis
- Patients with Hashimotos thyroiditis and Blastocystis Hominis infection
Exclusion Criteria
-Parasitic infections (other than Blastocystis hominis).
-Autoimmune diseases (Other than Hashimoto’s thyroiditis).
-Diabetes mellitus.
-Cardiovascular diseases.
-Malignancy & chronic inflammatory diseases.
-Pregnant or breastfeeding women.
-Patients receiving medications (including drugs affecting thyroid function).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on serum IL-17
- Secondary Outcome Measures
Name Time Method effect on thyroid profile